Skip to main content
Clinical Trials/CTRI/2024/05/066599
CTRI/2024/05/066599
Not yet recruiting
Phase 2

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF MASHADI GHRITA IN KSHEENA SHUKRA (OLIGOSPERMIA) - NI

Dr Vikrant0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: N461- Oligospermia
Sponsor
Dr Vikrant
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Vikrant

Eligibility Criteria

Inclusion Criteria

  • Patients who fulfill the diagnostic criteria.
  • Patients from any religion, occupation, or socio\-economic class.
  • Patients are willing to participate in the study and ready to sign the informed consent form.

Exclusion Criteria

  • Male patients with absolute Azoospermia and Teratozoospermia.
  • Male patients on certain medications like antineoplastic agents (e.g., Nitrogen mustard,
  • procarbazine, vincristine, methotrexate), cimetidine, estrogen and methyltestosterone.
  • Patients have chromosomal disorders like Klinefelter’s syndrome.
  • Patients suffering from major systemic disorders like Tuberculosis, AIDS and sexual
  • Transmitted Diseases (STD) and other gonadal disorders like Testicular Atrophy, Testicular
  • Failure and orchitis, which may interfere with study, will be excluded.
  • Patients having any anatomical deformity in gonads (e.g., Cryptorchidism, Monorchidism)

Outcomes

Primary Outcomes

Not specified

Similar Trials